FDA Premarket Cybersecurity in 2026
Episodes on premarket cybersecurity submissions, the FDA Refuse to Accept policy, and what the agency actually expects in 510(k), De Novo, and PMA filings.
FDA premarket cybersecurity is the foundation of getting a connected medical device cleared. The Refuse to Accept policy and the FDA's Final Premarket Cybersecurity Guidance mean cybersecurity documentation is no longer optional - it's a gating item. These episodes break down what reviewers look for: SBOMs, threat models, vulnerability assessments, secure product development frameworks, and labeling. Whether you're filing your first 510(k) or working through a complex De Novo, you'll find practical guidance from people who've lived it.
This page rounds up every FDA Premarket Cybersecurity conversation we've published in 2026 on The Med Device Cyber Podcast. Each episode pairs an experienced practitioner - a regulator, a startup founder, a security researcher, or a quality lead - with our hosts, who've personally led FDA premarket and postmarket cybersecurity submissions for connected medical devices. The result is a working library of frameworks, war stories, and reviewer-tested patterns you can apply to your own 510(k), De Novo, or PMA program.
Use the 2026 archive below to get a sense of how fda premarket expectations are evolving this year - what the FDA is asking for in deficiency letters, which engineering practices the field is converging on, and where reasonable people still disagree. If you want a longer-running view, browse the full FDA Premarket Cybersecurity topic page for every episode we've ever published on the subject, or jump to the complete 2026 catalog to see what else aired alongside these episodes.
